NCT02501291View on ClinicalTrials.gov

Thalidomide in Treating Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Crohn's Disease
Interventions
DRUG

Thalidomide

Trial Locations (1)

510080

The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT02501291 - Thalidomide in Treating Crohn's Disease | Biotech Hunter | Biotech Hunter